Research ArticleAccepted Article
Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus
Juan C. Quevedo-Abeledo, Hiurma Sánchez-Pérez, Beatriz Tejera-Segura, Laura de Armas-Rillo, Soledad Ojeda, Celia Erausquin, Miguel Á. González-Gay and Iván Ferraz-Amaro
The Journal of Rheumatology June 2020, jrheum.200435; DOI: https://doi.org/10.3899/jrheum.200435
Juan C. Quevedo-Abeledo
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Hiurma Sánchez-Pérez
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Beatriz Tejera-Segura
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Laura de Armas-Rillo
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Soledad Ojeda
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Celia Erausquin
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Miguel Á. González-Gay
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Iván Ferraz-Amaro
Division of Rheumatology, Hospital Doctor Negrín, Gran Canaria, Spain. Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Division of Rheumatology, Hospital Insular de Gran Canaria, Gran Canaria, Spain. Division of Health Sciences, Universidad Europea de Canarias, Tenerife. Spain. School of Medicine, University of Cantabria, Santander, Spain. Division of Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This work was supported by a grant to I.F-A. from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias grants PI14/00394, PI17/00083). Prof. González-Gay research is supported by the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigación Sanitaria grants PI06/0024, PI09/00748, PI12/00060, PI15/00525, PI18/00043) and the ISCIII RETICS programs (RD12/0009 and RD16/0012). Corresponding authors: Prof. Miguel Ángel González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Phone: +34 647 868 518; Fax: +34 922 646 792. Email: iferrazamaro@hotmail.com
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus
Juan C. Quevedo-Abeledo, Hiurma Sánchez-Pérez, Beatriz Tejera-Segura, Laura de Armas-Rillo, Soledad Ojeda, Celia Erausquin, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Jun 2020, jrheum.200435; DOI: 10.3899/jrheum.200435
Accepted manuscript
Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus
Juan C. Quevedo-Abeledo, Hiurma Sánchez-Pérez, Beatriz Tejera-Segura, Laura de Armas-Rillo, Soledad Ojeda, Celia Erausquin, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Jun 2020, jrheum.200435; DOI: 10.3899/jrheum.200435